{"result": "(\"entity\"<|>TIROIDES<|>GEO<|>Tiroides is a gland that produces hormones, including TSH and T4, which are crucial for metabolism and growth.)\n##\n(\"entity\"<|>BECK-PECCOZ P<|>PERSON<|>Beck-Peccoz P is an author of the European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors.)\n##\n(\"entity\"<|>LANIA A<|>PERSON<|>Lania A is a co-author of the European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors.)\n##\n(\"entity\"<|>BECKERS A<|>PERSON<|>Beckers A is a co-author of the European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors.)\n##\n(\"entity\"<|>CHATTERJEE K<|>PERSON<|>Chatterjee K is a co-author of the European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors.)\n##\n(\"entity\"<|>WEMEAU J-L<|>PERSON<|>Wemeau J-L is a co-author of the European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors.)\n##\n(\"entity\"<|>OLATEJU TO<|>PERSON<|>Olateju TO is an author who has written about thyroid hormone resistance.)\n##\n(\"entity\"<|>VANDERPUMP MP<|>PERSON<|>Vanderpump MP is an author who has written about thyroid hormone resistance.)\n##\n(\"entity\"<|>SINGHN BK<|>PERSON<|>Singhn BK is an author who has written a guide on understanding resistance to thyroid hormone due to receptor mutations.)\n##\n(\"entity\"<|>YEN PM<|>PERSON<|>Yen PM is a co-author of a clinician's guide to understanding resistance to thyroid hormone due to receptor mutations.)\n##\n(\"entity\"<|>HORMONAS TIROIDEAS<|>EVENT<|>Hormonas tiroideas are hormones produced by the thyroid gland that regulate metabolism and are involved in various physiological processes.)\n##\n(\"entity\"<|>TORNADO TIROIDEO<|>EVENT<|>Tormenta tiroidea is a clinical condition characterized by exacerbated hyperthyroidism symptoms, requiring urgent treatment.)\n##\n(\"relationship\"<|>BECK-PECCOZ P<|>EUROPEAN THYROID ASSOCIATION GUIDELINES<|>Beck-Peccoz P contributed to the guidelines for the diagnosis and treatment of TSH-secreting pituitary tumors<|>7)\n##\n(\"relationship\"<|>LANIA A<|>EUROPEAN THYROID ASSOCIATION GUIDELINES<|>Lania A contributed to the guidelines for the diagnosis and treatment of TSH-secreting pituitary tumors<|>7)\n##\n(\"relationship\"<|>BECKERS A<|>EUROPEAN THYROID ASSOCIATION GUIDELINES<|>Beckers A contributed to the guidelines for the diagnosis and treatment of TSH-secreting pituitary tumors<|>7)\n##\n(\"relationship\"<|>CHATTERJEE K<|>EUROPEAN THYROID ASSOCIATION GUIDELINES<|>Chatterjee K contributed to the guidelines for the diagnosis and treatment of TSH-secreting pituitary tumors<|>7)\n##\n(\"relationship\"<|>WEMEAU J-L<|>EUROPEAN THYROID ASSOCIATION GUIDELINES<|>Wemeau J-L contributed to the guidelines for the diagnosis and treatment of TSH-secreting pituitary tumors<|>7)\n##\n(\"relationship\"<|>OLATEJU TO<|>THYROID HORMONE RESISTANCE<|>Olateju TO has written about thyroid hormone resistance<|>6)\n##\n(\"relationship\"<|>VANDERPUMP MP<|>THYROID HORMONE RESISTANCE<|>Vanderpump MP has written about thyroid hormone resistance<|>6)\n##\n(\"relationship\"<|>SINGHN BK<|>THYROID HORMONE RESISTANCE<|>Singhn BK has authored a guide on understanding thyroid hormone resistance<|>6)\n##\n(\"relationship\"<|>YEN PM<|>THYROID HORMONE RESISTANCE<|>Yen PM has co-authored a guide on understanding thyroid hormone resistance<|>6)\n##\n(\"relationship\"<|>TIROIDES<|>HORMONAS TIROIDEAS<|>Tiroides produces hormones that include TSH and T4, which are classified as thyroid hormones<|>8)\n##\n(\"relationship\"<|>TORNADO TIROIDEO<|>HORMONAS TIROIDEAS<|>Tormenta tiroidea is a condition that involves the excessive production of thyroid hormones<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: hormonas tiroideas apoya el diagnóstico de resistencia.\nB. La elevación de la subunidad α es característica en los tirotropinomas.\nC. En los tirotropinomas es característica la disminución de la concentración de SHBG (globulina fijadora de hormonas sexuales).\nD. Los niveles de TSH se suprimen parcialmente tras la administración exógena de T3 en un 90% de los pacientes con resistencia a hormonas tiroideas.\n\n### COMENTARIO\n\nTanto los tumores productores de TSH como los cuadros de resistencia periférica a hormonas tiroideas presentan en el estudio de función tiroidea una TSH alta con T4L igualmente\n---\nTIROIDES                          3\n\nelevada. Sin embargo, algunas características analíticas pueden ayudar en su diagnóstico diferencial.\n\nLa presencia de una mutación en el gen del receptor de hormonas tiroideas lógicamente apoya que se trate de un cuadro de resistencia a hormonas tiroideas (opción A).\n\nAsimismo, la presencia de una elevación de la subunidad α apoya que se trate de un tumor hipofisario productor de TSH. Efectivamente, en estos tumores la subunidad α se encuentra elevada en el 70% de los casos e igualmente una relación elevada subunidad α/TSH está presente en el 80% de los tirotropinomas (opción B).\n\nTambién los niveles de SHBG (globulina fijadora de hormonas sexuales) son distintos en ambos cuadros. En los tirotropinomas, los niveles de SHBG están elevados (tiene un hipertiroidismo clínico), mientras que en los casos de resistencia a hormonas tiroideas son normales (no tiene hipertiroidismo clínico). Por lo tanto, la afirmación que figura en la opción C es falsa.\n\nFinalmente, la última afirmación es cierta. En efecto, debido a que la resistencia a hormonas tiroideas es siempre parcial, la administración exógena de hormonas tiroideas puede reducir los niveles de TSH. Sin embargo, esta reducción es parcial y variable según la dosis de hormona tiroidea administrada y no es específica de la T3.\n\nReferencias:\n- Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau J-L.. 2013 European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors. Eur Thyroid J. 2013;2:76-82.\n- Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab. 1990;71:19-25.\n- Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem. 2006;43:431-40.\n- Singhn BK, Yen PM. A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms. Clin Diabetes Endocrinol. 2017;3:8.\n\n## 18 En el tratamiento de la tormenta tiroidea, ¿cuál de los siguientes medicamentos no se ha mostrado útil?\n\nA. Tiamazol.\nB. Colestiramina.\nC. Solución de lugol.\nD. Todos pueden ser útiles.\n\nCOMENTARIO\n\nLa tormenta tiroidea o crisis tirotóxica es una condición clínica infrecuente, caracterizada por clínica de hipertiroidismo exacerbada. Tiene una mortalidad apreciable, alrededor de un 10% de los casos, por lo que un tratamiento enérgico y precoz es fundamental.\n\nLos antitiroideos en dosis altas son los fármacos de primera elección. Se recomienda iniciar tratamiento con 60 mg/día de tiamazol (opción A).\n\nOtra de las opciones de tratamiento es la colestiramina. En efecto, se ha utilizado en dosis de 4 mg, 2 o 4 veces al día, con objeto de reducir la reabsorción intestinal de las hormonas tiroideas metabolizadas por el hígado (opción B).\n\nJunto a los antitiroideos, otro pilar del tratamiento de la crisis tirotóxica es la administración de yodo inorgánico (opción C), dado que, a dosis elevadas, inhibe la oxidación y organificación del yodo por el tirocito (efecto Wolff-Chaikoff). Además, inhibe la liberación de las hormonas tiroideas, con lo que disminuye los niveles de hormonas tiroideas de una forma aún más rápida que los antitiroideos. La dosis recomendada son 200 mg diarios de yoduro potásico. Por lo tanto, todas las opciones pueden ser útiles (opción D correcta).\n\nReferencias:\n- Akamizu T, Satoh, Isozaki O, Suzuk A, Wakino S, Iburi T, et al,\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}